Samsung Bioepis Co., Ltd.

This study is testing if a new version of the cancer drug pembrolizumab (called SB27) behaves the same way in the body as two existing versions. It involves patients with early-stage lung cancer who have already had surgery and chemotherapy. The main goal is to compare how much d…

This study is testing if a new, potentially more affordable version of the cancer drug Keytruda (called SB27) works just as well for people with advanced non-small cell lung cancer. About 555 participants will receive either the new drug or the original, along with standard chemo…